Advanced HER2-positive Breast Cancer
3 clinical trials · Condition
◉ Watch Advanced HER2-positive Breast Cancer
| Record | Firm | Date |
|---|---|---|
| ARRY-380 + Trastuzuamab for Breast w/ Brain Mets (NCT01921335) | Dana-Farber Cancer Institute | 2013-08-01 |
| Combination of AUY922 With Trastuzumab in HER2+ Advanced Breast Cancer Patients Previously Treated With Trastuzumab (NCT01271920) | Novartis Pharmaceuticals | 2010-09-01 |
Track Advanced HER2-positive Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.